In addition, some emerging immune target studies have recently emerged, for example, lymphocyte activation gene 3 (LAG-3) overexpression in Tregs produces the immunosuppressive cytokines IL-10 and TGF-β, which inhibit the activity of effector T cells, and whose expression levels correlate with tumor progression and poor prognosis (238). Here, IL10 is linked to neoplasm.